Abstract
Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus that causes acute infection and establishes life-long latency. EBV causes several human cancers, including Burkitt’s lymphoma, nasopharyngeal and gastric carcinoma. Antiviral agents can be categorized as virucides, antiviral chemotherapeutic agents, and immunomodulators. Most antiviral agents affect actively replicating viruses, but not their latent forms. Novel antiviral agents must be active on both the replicating and the latent forms of the virus. Gardenia jasminoides is an evergreen flowering plant belonging to the Rubiaceae family and is most commonly found growing wild in Vietnam, Southern China, Taiwan, Japan, Myanmar, and India. Genipin is an aglycone derived from an iridoid glycoside called geniposide, which is present in large quantities in the fruit of G. jasminoides. In this study, genipin was evaluated for its role as an antitumor and antiviral agent that produces inhibitory effects against EBV and EBV associated gastric carcinoma (EBVaGC). In SNU719 cells, one of EBVaGCs, genipin caused significant cytotoxicity (70 μM), induced methylation on EBV C promoter and tumor suppressor gene BCL7A, arrested cell-cycle progress (S phases), upregulated EBV latent/lytic genes in a dose-dependent manner, stimulated EBV progeny production, activated EBV F promoter for EBV lytic activation, and suppressed EBV infection. These results indicated that genipin could be a promising candidate for antiviral and antitumor agents against EBV and EBVaGC.
This is a preview of subscription content, access via your institution.
References
Blake, N. 2010. Immune evasion by gammaherpesvirus genome maintenance proteins. J. Gen. Virol. 91, 829–846.
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., and Lipton, S.A. 1995. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with n-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92, 7162–7166.
Brulois, K. and Jung, J.U. 2014. Interplay between kaposi’s sarcoma-associated herpesvirus and the innate immune system. Cytokine Growth Factor Rev. 25, 597–609.
Dai, M.M., Wu, H., Li, H., Chen, J., Chen, J.Y., Hu, S.L., and Shen, C. 2014. Effects and mechanisms of Geniposide on rats with adjuvant arthritis. Int. Immunopharmacol. 20, 46–53.
Dinda, B., Debnath, S., and Harigaya, Y. 2007. Naturally occurring secoiridoids and bioactivity of naturally occurring iridoids and secoiridoids. A review, part 2. Chem. Pharm. Bull. (Tokyo) 55, 689–728.
Forrest, J.C. and Speck, S.H. 2008. Establishment of b-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of a DNA damage-signaling cascade. J. Virol. 82, 7688–7699.
Haruhiko, O. 2002. Methylation-specific PCR, pp. 91–97. In Bing-Yuan, C.H.W.J. (ed.), PCR cloning protocols, Humana, New York, USA.
Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K., et al. 2009. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 69, 2766–2774.
Hughes, D.J., Dickerson, C.A., Shaner, M.S., Sample, C.E., and Sample, J.T. 2011. Trans-repression of protein expression dependent on the epstein-barr virus promoter Wp during latency. J. Virol. 85, 11435–11447.
Ishiyama, M., Miyazono, Y., Sasamoto, K., Ohkura, Y., and Ueno, K. 1997. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44, 1299–1305.
Kang, H., Wiedmer, A., Yuan, Y., Robertson, E., and Lieberman, P.M. 2011. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog. 7, e1002140.
Kitano, A., Saika, S., Yamanaka, O., Reinach, P. S., Ikeda, K., Okada, Y., Shirai, K., and Ohnishi, Y. 2006. Genipin suppression of fibrogenic behaviors of the alpha-TN4 lens epithelial cell line. J. Cataract Refract. Surg. 32, 1727–1735.
Leonard, S., Wei, W., Anderton, J., Vockerodt, M., Rowe, M., Murray, P.G., and Woodman, C.B. 2011. Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of hodgkin’s lymphoma. J. Virol. 85, 9568–9577.
Liang, C., Lee, J.S., and Jung, J.U. 2008. Immune evasion in Kaposi’s sarcoma-associated herpes virus associated oncogenesis. Semin. Cancer Biol. 18, 423–436.
Lin, C.H., Chang, T.T., Sun, M.F., Chen, H.Y., Tsai, F.J., Chang, K.L., Fisher, M., and Chen, C.Y. 2011. Potent inhibitor design against H1N1 swine influenza: Structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database. J. Biomol. Struct. Dyn. 28, 471–482.
Liu, H., Chen, Y.F., Li, F., and Zhang, H.Y. 2013. Fructus gardenia (Gardenia jasminoides j. Ellis) phytochemistry, pharmacology of cardiovascular, and safety with the perspective of new drugs development. J. Asian Nat. Prod. Res. 15, 94–110.
Moon, S.H., Choi, H.J., Lee, S.J., and Choi, K.H. 1997. Novel genipin derivative having anti hepatitis B virus activity. Korea, Republic.
Moore, S.M., Cannon, J.S., Tanhehco, Y.C., Hamzeh, F.M., and Ambinder, R.F. 2001. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrob. Agents Chemother. 45, 2082–2091.
Oliver, F.J., de la Rubia, G., Rolli, V., Ruiz-Ruiz, M.C., de Murcia, G., and Murcia, J.M. 1998. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J. Biol. Chem. 273, 33533–33539.
Papa, S., Bubici, C., Zazzeroni, F., Pham, C.G., Kuntzen, C., Knabb, J.R., Dean, K., and Franzoso, G. 2006. The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 13, 712–729.
Roizman, B., Carmichael, L.E., Deinhardt, F., de-The, G., Nahmias, A.J., Plowright, W., Rapp, F., Sheldrick, P., Takahashi, M., and Wolf, K. 1981. Herpesviridae. Definition, provisional nomenclature, and taxonomy. The herpesvirus study group, the international committee on taxonomy of viruses. Intervirology 16, 201–217.
Son, M., Lee, M., Sung, G.H., Lee, T., Shin, Y.S., Cho, H., Lieberman, P.M., and Kang, H. 2013. Bioactive activities of natural products against herpesvirus infection. J. Microbiol. 51, 545–551.
Tempera, I., Klichinsky, M., and Lieberman, P.M. 2011. EBV latency types adopt alternative chromatin conformations. PLoS Pathog. 7, e1002180.
Tempera, I., Wiedmer, A., Dheekollu, J., and Lieberman, P.M. 2010. CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog. 6, e1001048.
Tseng, T.H., Chu, C.Y., Huang, J.M., Shiow, S.J., and Wang, C.J. 1995. Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett. 97, 61–67.
Tundis, R., Loizzo, M.R., Menichini, F., Statti, G.A., and Menichini, F. 2008. Biological and pharmacological activities of iridoids: Recent developments. Mini Rev. Med. Chem. 8, 399–420.
Ueda, S., Iwahashi, Y., and Tokuda, H. 1991. Production of antitumor-promoting iridoid glucosides in Genipa americana and its cell cultures. J. Nat. Prod. 54, 1677–1680.
Wille, C.K., Nawandar, D.M., Panfil, A.R., Ko, M.M., Hagemeier, S.R., and Kenney, S.C. 2013. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. J. Virol. 87, 935–950.
Young, L.S. and Rickinson, A.B. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757–768.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Son, M., Lee, M., Ryu, E. et al. Genipin as a novel chemical activator of EBV lytic cycle. J Microbiol. 53, 155–165 (2015). https://doi.org/10.1007/s12275-015-4672-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-015-4672-9
Keywords
- genipin
- Epstein-Barr virus
- lytic activation
- methylation